Clinical Trials in New York

Showing 2141-2160 of 22,668 trials

Phase II Trial of Lung Chemoemobolization

NCT05672108

This phase II trial evaluates how well transarterial chemoembolization (TACE) works for treating patients with non-small cell lung cancer or lung metastases. TACE is a minimally invasive procedure that involves injecting chemotherapy directly into an artery that supplies blood to tumors, and then blocking off the blood supply to the tumors. Mitomycin (chemotherapy), Lipiodol (drug carrier), and Embospheres (small plastic beads that block off the artery) are injected into the tumor-feeding artery. This traps the chemotherapy inside the tumor and also cuts off the tumor\'s blood supply. As a result, the tumor is exposed to a high dose of chemotherapy, and is also deprived of nutrients and oxygen. TACE can be effective at controlling or stopping the growth of lung tumors.

Lung Non-Small Cell CarcinomaMediastinal NeoplasmPleural Neoplasm+4 more

City of Hope Medical Center30 participantsStarted May 2023

Duarte, California, United States • New York, New York, United States

RECRUITINGPhase 1< 1 mile

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

NCT05433142

The purpose of this study is to assess the safety and tolerability of XmAb®819 administered intravenous (IV) or subcutaneous (SC) in subjects with relapsed or refractory clear cell renal cell carcinoma and to identify the minimum safe and biologically active dose and the recommended dose (RD).

Clear Cell Renal Cell Carcinoma

Xencor, Inc.307 participantsStarted Jun 2022

Phoenix, Arizona, United States • Duarte, California, United States • Sacramento, California, United States +20 more locations

Phase II Trial of Lung Chemoemobolization

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Find Trials by Condition in New York

A Pilot Study of SurVaxM in Children Progressive or Relapsed Medulloblastoma, High Grade Glioma, Ependymoma and Newly Diagnosed Diffuse Intrinsic Pontine Glioma

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma

Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

A Pilot Feasibility and Acceptability Study of Remote ExerciSe Training mOdalities (PRESTO)

Impella ECP Study (ECP Study) and Impella ECP Continued Access Protocol

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

Interview TIME: Training Inspired Minds for Employment

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery

A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons

Lumason® Infusion vs. Bolus Administrations

Study of DCC-3084 in Participants With Advanced Malignancies Driven by the Mitogen-Activated Protein Kinase (MAPK) Pathway

A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)